ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Zooming out on AI in biopharma — with Vijay Pande"
Episode Synopsis
Vijay Pande left Andreessen Horowitz this summer after 11 years as a life sciences investor. Now, he’s building a new firm focused on AI. He joins Post-Hoc Live to take the 10,000-foot view of AI in biotech and Silicon Valley: what do investors get right and wrong about biotech? What are the business models for AI in biopharma? Which moonshot project will stick? We’ll continue the conversation next week at Endpoints AI Day. Sign up for the virtual program here: https://events.endpoints.news/aiday2025
More episodes of the podcast Post-Hoc Live
The plan to make more custom CRISPR therapies — w Kiran Musunuru & Rebecca Ahrens-Nicklas
03/11/2025
The fight over Metsera
03/11/2025
Breaking down the XBI — with Josh Schimmer
10/09/2025
Choosing the Endpoints 11
03/09/2025
In God we trust